搜索临床试验以:保妥适渗透
总计1152个结果
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.主动,不招人恶性实体肿瘤 | 软组织肉瘤 | 复发性卵巢癌 | 三阴性乳腺癌 | 复发性骨肉瘤 | 难治性骨肉瘤 | 骨肉瘤 | 骨巨细胞瘤 | 卵巢癌肉瘤 | 铂类耐药卵巢癌 | 去分化软骨肉瘤 | 骨巨细胞瘤的恶性程度 | 低分化甲状腺癌 | 甲状腺间变性癌 | 甲状腺鳞状细胞癌 | 未分化高级别多形性骨肉瘤美国
-
Merz Pharmaceuticals GmbHLLC Merz Pharma, Russia完全的
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...招聘中
-
University of UtahUS Department of Veterans Affairs; U.S. Army Medical Research and Development Command完全的
-
Weill Medical College of Cornell UniversityAllergan; New York Presbyterian Hospital完全的
-
The Christie NHS Foundation TrustNational Institute for Health Research, United Kingdom终止
-
Imperial College LondonAstraZeneca撤销
-
Sidney Kimmel Comprehensive Cancer Center at Johns...完全的
-
National Cancer Institute (NCI)终止胃食管连接部腺癌 | IV 期胃癌 | 复发性胃癌 | 食管鳞状细胞癌 | 食管腺癌 | 复发性食道癌 | IV 期食管癌 | 胃弥漫性腺癌 | 胃肠腺癌 | 胃混合性腺癌 | IIIA期胃癌 | IIIB期胃癌 | IIIC期胃癌 | III期食道癌美国
-
Merck Sharp & Dohme LLC完全的
-
Saint Petersburg State University, RussiaUral State Medical University招聘中
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)招聘中
-
Johns Hopkins All Children's HospitalCannonball Kids' Cancer Foundation; Swim Across America Foundation; Benjamin Gilkey Fund尚未招聘
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.; The V Foundation for Cancer Research主动,不招人
-
Universidade do PortoCentro Hospitalar de Entre o Douro e Vouga; Centro Hospitalar de Vila Nova de Gaia/Espinho未知
-
Allergan完全的